Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Culture Vessel, Filtration), Consumables (Media, Reagent), Beads (Collagen, Cationic), Application (Vaccine, Cell & Gene Therapy), End User - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
The microcarriers market is projected to reach USD 3.3 billion by 2028 from an estimated USD 2.0 billion in 2023, at a CAGR of 10.0% during the forecast period. The growth of this market can be attributed to rising investments in cell & gene therapy research and growing technological advancements in single-use technologies.
The consumables segment accounted for the largest share by product in 2022.
The consumables segment accounted for the largest share of products in the global microcarriers market in 2022. Various factors such as the booming biopharmaceutical sector, growing investments, and government funding for the advancement of technologies are driving the demand for consumables in the microcarriers market. Additionally, the rising demand for high-quality reagents and media for cell therapies is promoting the growth of this market. Furthermore, the market share of the consumables market is expected to grow simultaneously with the growing cell-based research activities.
The Asia Pacific region is growing in the microcarriers market during the forecast period of 2023-2028.
The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. Various factors including the growing adoption of advanced technologies and the booming healthcare sector are propelling the growth of the microcarriers market in the region. The rising investments and geographic expansion of microcarriers by prominent players are promoting the growth of the microcarriers market. For instance, in December 2022, Thermo Fisher Scientific opened an 860,000 square-foot facility in Hangzhou, China, which is the company's first single-use manufacturing site in the Asia-Pacific region. The facility offers clinical and commercial drug substance and drug product capabilities, housing Thermo Fisher's HyPerforma single-use bioreactors and associated single-use equipment to a 2,000 L scale, catering to the demand for biologics production capabilities from customers in the region.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 278 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $2 Billion |
| Forecasted Market Value (USD) by 2028 | $3.3 Billion |
| Compound Annual Growth Rate | 10.0% |
| Regions Covered | Global |
Key Topics Covered:
Executive Summary
- Microcarriers Market, by Product, 2023 vs. 2028 (USD Million)
- Microcarriers Industry, by Application, 2023 vs. 2028 (USD Million)
- Market, by End-user, 2023 vs. 2028 (USD Million)
- Geographical Snapshot of Market
Premium Insights
- Microcarriers Market Overview -Increasing Demand for Cell-based Vaccines to Drive Market During Forecast Period
- North America: Microcarriers Industry, by Product - Consumables Segment Accounted for Largest Market Share in 2022
- Market, by End-user -Pharmaceutical & Biotechnology Companies Segment Accounted for Largest Market Share in 2022
- Market, by Application - Biopharmaceutical Production Segment Accounted for Largest Market Share in 2022
- Market: Geographic Growth Opportunities - Asia-Pacific Segment to Register Highest Growth Rate During Forecast Period
Market Dynamics
Drivers
- Growing Adoption of Microcarriers for Cell-based Vaccine Production
- Technological Advancements to Support Microcarrier-based Cell Production
- Rising Investments in Cell & Gene Therapy Research
- Growing Preference for Single-Use Technologies
- Increasing R&D Spending for Biopharmaceutical Production
Restraints
- High Cost of Cell Biology Research
- Limitations in High-Density Cell Culture Production
Opportunities
- Rising Demand for 3D Cell Culture
- Growing Demand for MABs and Biosimilars
- High-Growth Potential of Emerging Economies
Challenges
- High Costs Associated with Serum-Free Media
- Microcarrier-Cell Detachment
Companies Profiled
- BBI-Biotech
- Becton, Dickinson and Company
- Bionet
- Chemometec
- Corning
- Danaher
- Distek
- Entegris
- Eppendorf
- Esco Lifesciences Group
- Fujifilm Holdings
- G&G Technologies
- Getinge
- Kuhner
- Lonza
- Meissner Filtration Products
- Merck
- PBS Biotech
- Reprocell
- Sartorius
- Smart MCS
- Stemcell Technologies
- Stobbe Group
- Tantti
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/8c7e4j
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
